SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-22-014327
Filing Date
2022-04-13
Accepted
2022-04-13 13:56:32
Documents
1
Period of Report
2022-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3754
  Complete submission text file 0001140361-22-014327.txt   5351
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 37000 GRAND RIVER AVE SUITE 120 FARMINGTON HILLS MI 48335
Business Address
Pepose Jay (Reporting) CIK: 0001866191 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 22824352